Virus

A new viral protein structure could jump-start vaccine development for two leading causes of lower respiratory disease in children and elderly adults. Read More

New details about the life cycle of respiratory syncytial virus (RSV) could aid the development of therapies to combat this leading cause of serious illness in infants and the elderly. Read More

Antibodies to the 2009 H1N1 influenza strain reveal new insights into how antibody diversity forms and functions, with possible implications for designing flu vaccines. Read More

This Week on VUCast: Why a Vanderbilt disease expert says the medical thriller “Contagion” may be closer to reality than you think [ watch full video of Dr. Creech and more information about vaccines ] Why it’s worth going to… Read More